Generic selectors
Exact matches only
Search in title
Search in content
Filter by Categories
A Case Report
Aeromedical Assessment
Aeromedical Decision Making
Aeromedical Evaluation
Aerospace Medicine Quiz
Aviation Physiology
Book Review
Case Report
Case Series
Case Study
Clinical Series
Concept Paper
Contemporary Issue
Contemporary issues
Current Issue
Exploring Space
Field Experience
Field Report
Field Study
Field Trials
Guest Editorial
Know your President
Letter to Editor
Letter to the Editor
Letters to the Editor
Methods in Aerospace Medicine
Methods in Medicine
Original Article
Original Article (Field Study)
Original Research
Review Article
Short Communication
Society Calender
Society News
Teaching Series
Technical Communication
View/Download PDF

Translate this page into:

Aviation Physiology
49 (
); 69-70

Aviation Physiology: Teaching Series Pulmonary Function Test

Brief case history

A 35 year old male presented with history of cough and breathlessness on exertion of 6 months duration. He was referred for spirometry as part of the medical evaluation. The test was carried out and the report is placed below. Comment on the findings.

Findings and interpretation

The test has been carried out before and after administering an inhaled bronchodilator.

  1. The pre-bronchodilator results revealed:-

    1. FEV1% of 71.5

    2. FEV1 59% of predicted value

    3. FVC 68.9% of predicted value

    4. PEF 58.8% of predicted

    5. Forced Expiratory flows substantially reduced.

    The reduced FEV1% suggests an obstructive impairment. This is supported by an FEV1, which is 59% of the predicted value. The FVC, which is 68.9% of predicted, may indicate a borderline restrictive impairment.

  2. The post-bronchodilator results revealed:-

    1. FEV1 88.9% of predicted value – an improvement of 50.8% (980 ml)

    2. FVC 95.7% of predicted value – an improvement of 38.9% (1050 ml)

    3. FEV1% of 77.6

    4. PEF 79.8% of predicted

    5. Forced Expiratory flows improved

The improvement in the FEV1 and FVC is more than 12.5% of the pre-bronchodilator values as well as greater than 200 ml. This signifies reversible obstructive impairment. The fact that the FVC improved after bronchodilator administration rules out the presence of a restrictive impairment.


  1. Reduced FVC values do not necessarily signify restrictive impairment. A reduced FVC may be seen in obstructive diseases as well. Response to an inhaled bronchodilator can help differentiating the two. FVC reductions due to an underlying restriction will not improve with bronchodilators.

  2. Post-bronchodilator test should be carried out 20 minutes after the inhalation of the drug in case a beta agonist drug is used. For anti-cholinergic drugs, this time period increases to 45 minutes. Failure to ensure this may lead to inaccurate comments on the nature of obstruction present in the lungs.

  3. Reversibility of obstruction is commented based on the magnitude of improvement in the FEV1 and or FVC only. There should be an improvement of at least 12.5% as well as an increase of at least 200 ml volume. Both the criteria must be fulfilled to label an obstruction as reversible.

  4. PEF is not a parameter that should be used to determine the presence of or the reversibility of an airway obstruction. This parameter is highly effort dependent as well as poorly reproducible.

Further reading

  1. Standardization of Spirometry. 1994 update. J Respir Crit Care Med 1995;152:1107-36.

  2. Guidelines for the measurement of respiratory function. Recommendations of the British Thoracic Society and Association of Respiratory Technicians and Physiologists. Respiratory Medicine 1994; 88: 165-94.

Contributed by :

Major Anuj Chawla

Assistant Professor Physiology

Institute of Aerospace Medicine, IAF, Bangalore

Show Sections